Citation

Dragovich PS, Prins TJ, Zhou R, Johnson TO, Hua Y, Luu HT, Sakata SK, Brown EL, Maldonado FC, Tuntland T, Lee CA, Fuhrman SA, Zalman LS, Patick AK, Matthews DA, Wu EY, Guo M, Borer BC, Nayyar NK, Moran T, Chen L, Rejto PA, Rose PW, Guzman MC, Dovalsantos EZ, Lee S, McGee K, Mohajeri M, Liese A, Tao J, Kosa MB, Liu B, Batugo MR, Gleeson JP, Wu ZP, Liu J, Meador JW, Ferre RA.: Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. J Med Chem, Volume 46 (21), 2003

Authors

Batugo MR, Borer BC, Brown EL, Chen L, Dovalsantos EZ, Dragovich PS, Ferre RA., Fuhrman SA, Gleeson JP, Guo M, Guzman MC, Hua Y, Johnson TO, Kosa MB, Lee CA, Lee S, Liese A, Liu B, Liu J, Luu HT, Maldonado FC, Matthews DA, McGee K, Meador JW, Mohajeri M, Moran T, Nayyar NK, Patick AK, Prins TJ, Rejto PA, Rose PW, Sakata SK, Tao J, Tuntland T, Wu EY, Wu ZP, Zalman LS, Zhou R

Journal

J Med Chem

Year

2003

DOI

10.1021/jm030166l

PubMed

14521419

Machine-readable

REST APIRDF